Cargando…

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine

Several SARS-CoV-2 vaccines have received EUAs, but many issues remain unresolved, including duration of conferred immunity and breadth of cross-protection. Adjuvants that enhance and shape adaptive immune responses that confer broad protection against SARS-CoV-2 variants will be pivotal for long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Jangra, Sonia, Landers, Jeffrey J., Rathnasinghe, Raveen, O’Konek, Jessica J., Janczak, Katarzyna W., Cascalho, Marilia, Kennedy, Andrew A., Tai, Andrew W., Baker, James R., Schotsaert, Michael, Wong, Pamela T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481386/
https://www.ncbi.nlm.nih.gov/pubmed/34603303
http://dx.doi.org/10.3389/fimmu.2021.729189